VTGN (Vistagen Therapeutics, Inc.) Stock Market Reviews

crown

search

Read and share opinions on VTGN (Vistagen Therapeutics, Inc.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock mar

VTGN

Vistagen Therapeutics, Inc.

clarify Biotechnology

bookmark Healthcare

public United States

Sell Neutral Buy

Latest News

Vistagen Therapeutics Inc (VTGN) Q2 2026 Earnings Call Highlights: Progress in Palisade 3 Trial ...
Nov 14, 2025
VistaGen Therapeutics, Inc. (VTGN) Reports Q2 Loss, Lags Revenue Estimates
Nov 13, 2025
Vistagen Reports Fiscal Year 2026 Second Quarter Financial Results and Provides Corporate Update
Nov 13, 2025
Vistagen to Report Fiscal Year 2026 Second Quarter Results and Host Corporate Update Conference Call on November 13, 2025
Nov 10, 2025
Vistagen to Participate in Stifel Healthcare Conference 2025
Nov 5, 2025
Vistagen Completes PALISADE-3 Phase 3 Public Speaking Challenge Study for the Acute Treatment of Social Anxiety Disorder
Nov 3, 2025
Vistagen Appoints Paul Edick to its Board of Directors
Oct 29, 2025
Vistagen to Present at The Menopause Society 2025 Annual Meeting
Oct 16, 2025
Vistagen to Present at the TD Cowen 5th Annual Novel Mechanisms in Neuropsychiatry & Epilepsy Summit
Sep 9, 2025
Vistagen Therapeutics, Inc. (VTGN) Eyes Breakthrough with Phase 3 Social Anxiety Trial
Sep 2, 2025
Vistagen Therapeutics Inc (VTGN) Q1 2026 Earnings Call Highlights: Advancing Key Trials Amid ...
Aug 8, 2025

Reviews